PAREXEL International Corporation, a biopharmaceutical services company, provides clinical research, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics (Perceptive). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. This segment manages various aspects of clinical trials, including study and protocol design, case report form design, paper or electronic questionnaires design, patient enrollment, study monitoring and data collection, data analysis, report writing, and medical services. The PCMS segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, and good manufacturing practice compliance consulting; and market development, product development, and targeted communications services in support of product launch. Its consultants also identify alternatives and propose solutions to address clients product development, registration, and commercialization issues. In addition, this segment provides reimbursement and market access services. The Perceptive segment provides information technology solutions comprising medical imaging and systems integration services; ClinPhone RTSM, CTMS, and DataLabs EDC products; Web-based portals; and patient diary applications. The company was founded in 1983 and is headquartered in Waltham, Massachusetts.
Roam Analytics operates a machine learning platform specifically designed for the healthcare sector, transforming the analysis of patient and provider pathways. Its core offering, the Roam Health Knowledge Graph™, organizes healthcare entities—such as drugs, devices, diseases, and providers—based on meaningful relationships derived from diverse data sources. This structured data ontology allows for the integration of both structured and unstructured data, creating a comprehensive asset that enhances visibility into the healthcare industry. By leveraging this platform, healthcare companies can better analyze language data, leading to improved development, marketing, and outreach across various therapeutic areas. Ultimately, Roam Analytics aims to unlock the value of existing data, enabling healthcare organizations to make more informed decisions and improve overall healthcare outcomes.
The Medical Affairs Company LLC is a contract medical organization based in Kennesaw, Georgia, specializing in medical and scientific affairs solutions for the pharmaceutical, biotechnology, and medical device industries. The company offers a range of services, including medical science liaison (MSL) programs, MSL training, medical communications support, and consulting services. Its innovative tools, such as mslConnect and i-MSL, enhance connectivity and facilitate clinical consultations between MSLs and stakeholders. The Medical Affairs Company also provides additional services such as pharmacovigilance, medical writing, peer-to-peer scientific interactions, and medical meeting support. Founded in 2007, the company has approximately 200 employees and operates as a subsidiary of PAREXEL International Corporation.
ExecuPharm Inc. is a functional service contract research organization (CRO) based in King of Prussia, Pennsylvania, with a global presence that includes locations in Canada, Mexico, Argentina, the United Kingdom, India, China, and Japan. The company specializes in providing comprehensive clinical research support services tailored for the biopharmaceutical industry. Its offerings encompass a wide range of services, including clinical trial management, monitoring, site management, and regulatory oversight, as well as document and data management. ExecuPharm employs flexible service models and advanced technologies to address the specific needs of clinical trials. With a management team experienced in clinical operations, the company is adept at navigating the complexities of clinical outsourcing and staffing. ExecuPharm emphasizes local expertise, ensuring its specialists are familiar with regional customs and regulatory requirements, which facilitates efficient trial execution. Founded in 1995, ExecuPharm is recognized for its high employee retention rates and rapid deployment of project resources, contributing to strong client relationships and repeat business.
Health Advances, LLC is a strategy consulting firm founded in 1992 and headquartered in Weston, Massachusetts, with additional offices in Boston, San Francisco, Washington, D.C., and Zug, Switzerland. The firm specializes in providing strategic consultancy services to the healthcare industry, including pharmaceutical, biotechnology, medical device, and diagnostics companies, as well as their investors. Health Advances offers a comprehensive range of services such as clinical development strategy, due diligence, market assessment and forecasting, lifecycle management, mergers and acquisitions strategy, and technology commercialization. The firm also focuses on areas like autoimmune diseases, oncology, respiratory conditions, and personalized medicine, leveraging analytics and insights to aid clients in navigating the complexities of the healthcare market.
Quantum Solutions India is a contract research organization established in 2004, based in Chandigarh, India. The company specializes in drug safety services for the pharmaceutical industry, offering a comprehensive range of pharmacovigilance services. These include processing individual case safety reports, conducting literature reviews, and producing aggregate report writings. Quantum Solutions also provides medical writing services, which encompass safety narratives, clinical study protocols, and risk management plans. Additionally, the organization conducts literature searches and reviews across multiple therapeutic areas such as oncology, cardiology, and immunology. With a workforce of approximately 900 employees, Quantum Solutions India serves clients globally, including those in the pharmaceutical, medical device, and consumer sectors. As of 2015, it operates as a subsidiary of PAREXEL International Corporation.
ClinIntel Ltd.
Acquisition in 2014
ClinIntel is a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom. ClinIntel was founded in 2009, and works with biopharmaceutical companies and contract research organizations.
ATLAS provides services across all phases of clinical development and has therapeutic expertise in Oncology, Hematology, Endocrinology, Cardiovascular, Anesthesiology, Infectious Diseases and the Central Nervous System. The firm also provides clinical trial-related services from study planning and feasibility, through site selection, data management and medical writing. ATLAS also provides regulatory services and can support product registration. - See more at: https://www.parexel.com/organization/news-events/press-releases/2014/parexel-international-announces-acquisition-atlas-medical-services-provider-clinical-research-services-turkey#sthash.mKquI29x.dpuf
HERON Group Ltd.
Acquisition in 2013
HERON Group LTD (“HERON”) is a life sciences consultancy which provides evidence-based commercialization services to support biopharmaceutical companies throughout the lifecycle of their products. HERON has expertise and methodologies spanning a wide range of services, including strategic market access planning, systematic reviews, economic modeling and evaluation, pricing, reimbursement strategies, global value dossier writing, and engagement with Health Technology Assessment authorities.
Liquent, Inc. provides content assembly and publishing solutions for the life sciences industry. Its solutions include CoreDossier, which manages the compliance information; kPublisher that is used to prepare the reports and documents; kPortal, which enables various publications to be managed through the Web-browser; Liquent Xtent, a content middleware that converts business information assets into formats that are easily distributed; and ExSource Solution, which is used as a consulting and outsourcing resource for the publishing arena. Its customers include pharmaceutical manufacturers; biotechnology, medical devices, veterinary medicine and agrochemicals, generic drugs, government agencies, pharma manufacturing, and food and cosmetics industries. The company was founded as Electronic Submission Publishing Systems, Inc. in 1994 and changed its name to Liquent, Inc. in 2001. Liquent is headquartered in Fort Washington, Pennsylvania. Liquent, Inc. was formerly a subsidiary of Information Holdings Inc. Liquent, Inc. is a subsidiary of Thomson Reuters Corporation.
ClinPhone is a clinical technology organization based in Nottingham, United Kingdom. The company specializes in developing integrated telephone and web-based systems designed to enhance the quality and cost-effectiveness of data capture and transfer in clinical trials. By providing innovative solutions, ClinPhone supports pharmaceutical and biotechnology companies in improving their clinical trial processes.
PAREXEL APEX International Co., Ltd.
Acquisition in 2007
APEX International Clinical Research Co., Ltd. (“APEX”). APEX providing clients with a wide range of clinical research service offerings throughout the Asia-Pacific region, including mainland China, Hong Kong, India, Taiwan, Singapore, Indonesia, South Korea, Malaysia, Thailand, the Philippines, New Zealand, and Australia.
California Clinical Trials Medical Group, Inc.
Acquisition in 2006
California Clinical Trials Medical Group, Inc. (“CCT”). Established in 1981 with headquarters in San Diego, provide a broad range of specialty Phase I – IV clinical research services through four clinical sites in California.
Behavioral and Medical Research LLC
Acquisition in 2006
Behavioral and Medical Research, LLC (“BMR”). Established in 1981 with headquarters in San Diego, provide a broad range of specialty Phase I – IV clinical research services through four clinical sites in California.
Perceptive Informatics, Inc.
Acquisition in 2005
Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak.
QdotPharma is a clinical pharmacology business based in George, South Africa, established in 1996. The company specializes in Phase I and IIa Proof of Concept clinical studies, focusing on therapeutic areas such as central nervous system, psychiatric, cardiovascular, and metabolic conditions. With 32 beds available for patient trials, QdotPharma provides a range of clinical research services tailored for the pharmaceutical industry. These services include conducting clinical studies, as well as offering investigator, contract research organization (CRO), site management organization (SMO), and data management support.
Integrated Marketing Concepts
Acquisition in 2004
Integrated Marketing Concepts specializes in clinical trial patient recruitment and retention, sales lead management, teleservices, call center services, fulfillment, focus group and database management, and market research. IMC serves a diversified client base across a wide array of industries, including pharmaceutical and biotechnology companies, and drug manufacturers. The Company employs approximately 50 individuals at its headquarters in Whitehall, PA.
3ClinicalResearch AG
Acquisition in 2004
3ClinicalResearch AG (“3C”) is a clinical research organization. The privately held company based in Berlin, Germany.
FW Pharma Systems Ltd.
Acquisition in 2003
FW Pharma Systems Ltd., is a software company that delivers enterprise-wide clinical trial management systems (CTMS). The privately held company is based in Birmingham, United Kingdom.
Pracon & HealthIQ
Acquisition in 2002
Pracon & HealthIQ provides services to pharmaceutical, biotech, and medical device companies in the areas of reimbursement assistance services, communications, and competitive intelligence. Founded in 1976.
Invantage, Inc.
Acquisition in 2002
Established in 1994, Invantage has focused on the development of solutions that expedite clinical study start-up via a portfolio of advanced software applications and associated services. Invantage’s flagship product, the Investigator DataWeb Enterprise Edition, is a sophisticated web-based data repository of potential clinical investigators combined with a decision support environment for initiating clinical trials. The product was developed in conjunction with a number of major pharmaceutical companies.
EDYABE
Acquisition in 2001
EDYABE is a clinical research organization in Latin America located in Argentina and Brazil.
FARMOVS-PAREXEL is an established pharmacology research unit and bioanalytical laboratory dedicated to performing clinical pharmacology studies. Trials conducted at this unit include, but are not limited to, proof-of-concept, drug interaction, single and multiple dose, specialized PK/PD and biomarker, glucose clamp, spiro-ergometry, and recombinant vaccine studies. It is a part of the PAREXEL Clinical Pharmacology Network that includes Clinical Pharmacology Research Units in Baltimore, Maryland; Berlin, Germany; London, United Kingdom and bioanalytical laboratories in Bloemfontein and Poitiers, France offering more than 500 validated assay methods.
CEMAF SA
Acquisition in 1999
CEMAF S.A., is a Phase I clinical research and bioanalytical laboratory located in Poitiers, France.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.